Janux Therapeutics gains amid renewed takeover speculation [Seeking Alpha]
Goldman Sachs Group, Inc. (The) (GS)
Last goldman sachs group, inc. (the) earnings: 4/15 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
goldmansachs.com/investor-relations
Company Research
Source: Seeking Alpha
Merck ( MRK ) is rumored to be one of the parties involved in the Janux ( JANX ) strategic alternatives review, according to a Betaville "uncooked alert" on Thursday, which cited people following the matter. Goldman Sachs is speculated to be advising Merck, according to the report. Shares of Janux ( JANX ) soared 23% over two days in early April after Bloomberg reported that the cancer drugmaker was weighing its options after getting takeover interest from larger pharma companies. The biotech firm, which develops tumor-activated immunotherapies for cancer treatment, is working with a financial adviser to consider its options, including a sale, Janux ( JANX ) was expected to garner interest from larger pharma companies who want to replenish their portfolios or expand into cancer treatment, according to the report. Talks are ongoing and there is no certainty that a sale will occur. Janux shares have surged 53% since the Bloomberg report. Recommended For You More Trending News
Show less
Read more
Impact Snapshot
Event Time:
GS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GS alerts
High impacting Goldman Sachs Group, Inc. (The) news events
Weekly update
A roundup of the hottest topics
GS
News
- Timken Prices €600 Million Senior Notes Due in 2034 [Yahoo! Finance]Yahoo! Finance
- 3 tricks legacy media companies can learn from social-video platforms, per a new Accenture report [Business Insider]Business Insider
- Small Business Owners Poised to Impact Upcoming Elections, New Survey Finds [Yahoo! Finance]Yahoo! Finance
- Dow shoots past 40,000 for the first time on hopes that Fed will follow cooler inflation print with rate cuts [Fortune]Fortune
- The Dow just crossed 40,000 for the first time. The number is big but means little for your 401(k) [Yahoo! Finance Canada]Yahoo! Finance Canada
GS
Earnings
- 4/15/24 - Beat
GS
Sec Filings
- 5/16/24 - Form 424B2
- 5/16/24 - Form 424B2
- 5/16/24 - Form FWP
- GS's page on the SEC website